BioArctic AB (publ) (BRCTF)

Market Cap	3.17B +91.5%
Revenue (ttm)	216.89M +676.8%
Net Income	110.91M
EPS	1.25
Shares Out	n/a
PE Ratio	28.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	7
Open	33.02
Previous Close	33.02
Day's Range	33.02 - 33.02
52-Week Range	17.98 - 40.00
Beta	-0.78
RSI	86.48
Earnings Date	Apr 21, 2026

About BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of innovative biological drugs, such as antibodies that address high unmet medical needs. The company’s therapeutic areas encompass neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and other CNS diseases. In addition, it owns a technology platform, which develops a range of therapeutic monoclonal antibodies. Additionally, the company is developing lecanemab, which is...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 129
• Stock Exchange: OTCMKTS
• Ticker Symbol: BRCTF

Financial Performance

Financial numbers in SEK